US 6743791
Heterocyclic inhibitors of ERK2 and uses thereof
expired A61PA61P1/16A61P11/00
Quick answer
US patent 6743791 (Heterocyclic inhibitors of ERK2 and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 57
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P17/06, A61P19/00